Studies on the metabolic pattern of propiverine in urine after single administration.
In 11 healthy volunteers the metabolic pattern of propiverine [1; alpha, alpha-diphenyl-n-propoxy-1, 2-acetic acid-4-(1-methyl-piperidinyl)ester] was studied in urine after a single i.v. (5 mg) or oral dose (15 mg). To each dose 30.4 microCi (1.11 MBq) 14C-1 were added. The various urine fractions (0-1, 1-4, 4-8, 8-24 h) were extracted by chloroform and ethyl acetate at different pH-values and TLC was performed. The metabolites were identified by comparison of the RF-values of the radiochromatograms with those of the reference compounds after TLC using various solvent mixtures. Evidence for identity of the metabolites was additionally obtained by ester hydrolysis, ether cleavage or reduction with subsequent TLC after elution of the spots from the plate. The formed products were rechromatographed. 1 undergoes an extensive biotransformation: about 70% of the radioactive substances in urine consisted of 19 different metabolites, while 1 amounted to only 3%. Additionally, 3 acidic metabolites of unknown structure were isolated. Due to the metabolic pattern the following reactions of degradation were found: oxidation of the tertiary nitrogen in the piperidinyl moiety yielding N-oxides (40 to 50% of radioactivity), oxidation of one of the three carbon atoms of the propyl side chain, oxidation of the N-methyl group resulting in N-demethylated products, and ester cleavage. Propiverine N-oxide (20 to 25%) was determined as a major metabolite, whereas demethylated products occurred in minute amounts (1%). There was no evidence for oxidation of both phenyl moieties.
Hüller
G
G
Institute of Clinical Pharmacology, VEB Sächsisches Serumwerk Dresden.
Haustein
K O
KO
Scheithauer
S
S
D000328:Adult; D000588:Amines / Q000652:urine; D001561:Benzilates / Q000652:urine*; D001711:Biotransformation; D002855:Chromatography, Thin Layer; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007783:Lactones / Q000652:urine; D008297:Male; D010087:Oxides / Q000652:urine; D010276:Parasympatholytics / Q000652:urine*; D012997:Solvents
D000588:Amines; D001561:Benzilates; D007783:Lactones; D010087:Oxides; D010276:Parasympatholytics; D012997:Solvents; C015586:propiverine